Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity

Journal of Magnetic Resonance Imaging

Volumn 31, Issue 3, 2010, Pages 538-548

  Ellingson, Benjamin M ^a   Malkin, Mark G ^a   Rand, Scott D ^a   Connelly, Jennifer M ^a   Quinsey, Carolyn ^a   LaViolette, Pete S ^a   Bedekar, Devyani P ^a   Schmainda, Kathleen M ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Brain tumor; Diffusion MRI; fDM; Functional diffusion maps; Glioma

Indexed keywords

BIOLOGICAL MARKER; CORTICOSTEROID; GADOBENATE DIMEGLUMINE; GADODIAMIDE;

ARTICLE; BRAIN RADIOGRAPHY; CANCER GROWTH; CELL DENSITY; CEREBROSPINAL FLUID; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DISEASE COURSE; FEMALE; FUNCTIONAL DIFFUSION MAP; GLIOMA; GLIOMA CELL; GRAY MATTER; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION WEIGHTED IMAGING; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STEREOTACTIC BIOPSY; VALIDATION STUDY; WHITE MATTER;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; BRAIN NEOPLASMS; COMPUTER SIMULATION; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; GLIOMA; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 77649224700     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22068     Document Type: Article

References (27)

1. Sugahara T, Korogi Y, Kochi M, et al. Usefulness of diffusionweighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 1999;9:53-60.
2. Lyng H, Haraldseth O, Rofstad EK. Measurements of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging. Magn Reson Med 2000;43:828-836.
3. Chenevert TL, Stegman LD, Taylor JM, et al. Diffusion magnetic resonance imaging: an early surrogate marker for therapeutic efficacy in brain tumors. J Natl Cancer Inst 2000;92:2029-2036.
4. Hayashida Y, Hirai T, Morishita S, et al. Diffusion-weighted imaging of metastatic brain tumors: comparison with histologic type and tumor cellularity. AJNR Am J Neuroradiol 2006;27:1419-1425.
5. Manenti G, Di Roma M, Mancino S, et al. Malignant renal neoplasms: correlation between ADC values and cellularity in diffusion weighted magnetic resonance imaging at 3 T. Radiol Med 2008;113:199-213.
6. Gauvain KM, McKinstry RC, Mukherjee P, et al. Evaluating pediatric brain tumor cellularity with diffusion-tensor imaging. AJR Am J Roentgenol 2001;177:449-454.
7. Kinoshita M, Hashimoto N, Goto T, et al. Fractional anisotropy and tumor cell density of the tumor core show positive correlation in diffusion tensor magnetic resonance imaging of malignant tumors. Neuroimage 2008;43:29-35.
8. Kono K, Inoue Y, Nakayama K, et al. The role of diffusionweighted imaging in patients with brain tumors. AJNR Am J Neuroradiol 2001;22:1081-1088.
9. Chenevert TL, McKeever PE, Ross BD. Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. Clin Cancer Res 1997;3:1457-1466.
10. Moffat BA, Chenevert TL, Lawrence TS, et al. Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci U S A 2005;102:5524-5529.
11. Moffat BA, Chenevert TL, Meyer CR, et al. The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome. Neoplasia 2006;8:259-267.
12. Hamstra DA, Galbán CJ, Meyer CR, et al. Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with convensional radiologic response and overall survival. J Clin Oncol 2008;26:3387-3394.
13. Hamstra DA, Chenevert TL, Moffat BA, et al. Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma. Proc Natl Acad Sci U S A 2005;102:16759-16764.
14. Cox RW, Jesmanowicz A. Real-time 3D image registration for functional MRI. Magn Reson Med 1999;42:1014-1018.
15. Ellingson BM, Malkin MG, Rand SD, Bedekar DP, Schmainda KM. Functional diffusion maps applied to FLAIR abnormal areas are valuable for the clinical monitoring of recurrent brain tumors. Proc Intl Soc Mag Reson Med 2009;17:285.
16. Ellingson BM, Malkin MG, Rand SD, Hoyt A, Connelly J, Bedekar DP, Kurpad SN, Schmainda KM. Comparison of cytotoxic and anti-angiogenic treatment responses using functional diffusion maps in FLAIR abnormal regions. Proc Intl Soc Mag Reson Med 2009;17:1010.
17. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM, editor. Evaluation of chemotherapeutic agents. New York: Columbia University Press; 1949. p 191-205.
18. Mor V, Laliberte L, Morris JN, Wiemann M. The Karnofsky performance scale: an examination of its reliability and validity in a research setting. Cancer 1984;53:2002-2007.
19. Macdonald DR, Cascino TL, Schold SC Jr, Cairncross JG. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 1990;8:1277-1280.
20. Gupta RK, Cloughesy TF, Sinha U, et al. Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human gliomas. J Neurooncol 2000;50:215-226.
21. Mørk S, Laerum OD, deRitter L. Invasiveness of tumours of the central nervous system. In: Mareel MM, Calman K, editors. Tumor invasion. New York, NY: Oxford University Press; 1984. p 79-125.
22. Armitage PA, Schwindack C, Bastin ME, Whittle IR. Quantitative assessment of intracranial tumor response to dexamethasone using diffusion, perfusion and permeability magnetic resonance imaging. Magn Reson Imaging 2007;25:303-310.
23. Swanson KR, Alvord EC Jr, Murray JD. A quantitative model for differential motility of gliomas in grey and white matter. Cell Prolif 2000;33:317-329.
24. Swanson KR, Bridge C, Murray JD, Alvord EC Jr. Virtual and real brain tumors: using mathematical modeling to quantify glioma growth and invasion. J Neurol Sci 2003;16:1-10.
25. Murray JD. Mathematical biology. New York, NY: Springer-Verlag; 2002.
26. Ardekani BA, Guckemus S, Bachman A, Hoptman MJ, Wojtasek M, Nierenberg J. Quantitative comparison of algorithms for intersubject registration of 3D volumetric brain MRI scans. J Neurosci Methods 2005;142:67-76.
27. Padhani AR, Liu G, Mu-Koh D, et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 2009;11:102-125.